Skip to main content
AMTB
NYSE Finance

Amerant Bank Subsidiary Sells $49.7 Million in Loans to Peachtree Group

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Bank Stocks · Financial
Sentiment info
Neutral
Importance info
8
Price
$20.19
Mkt Cap
$833.153M
52W Low
$15.62
52W High
$24.4
52W Position info
29% above low
Off High info
17% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

AMTB sits 29% above its 52-week low of $15.62.

Summary

Amerant Bank, a subsidiary of Amerant Bancorp Inc., completed the sale of three loans totaling approximately $49.7 million to Peachtree Group, a move to optimize its loan portfolio.


Key Events · Financing and Capital Events · AMTB

  • Material Definitive Agreement

    Amerant Bank, N.A., a subsidiary of Amerant Bancorp Inc., entered into an Asset Sale Agreement with Peachtree Group.

  • Loan Portfolio Sale

    The Bank sold three loans to Peachtree Group for a total purchase price of approximately $49.7 million.

  • Initial Agreement Scope

    The agreement initially covered the sale of up to five loans with an estimated outstanding principal balance of $74.0 million.

  • Closing Date

    The transaction closed on January 7, 2026, following the agreement signed on December 31, 2025.


Analysis · AMTB · Finance

Amerant Bank, a wholly-owned subsidiary of Amerant Bancorp Inc., completed a substantial sale of loans. This transaction, involving three loans for approximately $49.7 million, represents a significant portfolio adjustment for the bank. While the filing does not specify the nature of these loans (e.g., performing vs. non-performing), such sales are typically undertaken to manage asset quality, enhance liquidity, or reallocate capital. For a financial institution, actively managing its loan portfolio through sales can be a strategic move to de-risk the balance sheet or free up funds for new lending opportunities, thereby improving overall financial health.

How filings like this one have moved

In the 30 days to Oct 5, 2026, 36.9% of the 964 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.65%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, AMTB was trading at $20.19 on NYSE in the Finance sector, with a market capitalization of approximately $833.2M. The 52-week trading range was $15.62 to $24.40. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

AMTB - Latest Insights

AMTB
Sep 15, 2026, 8:26 AM EDT
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $29.55
Real-time Price: $29.56 info
Change: +$0.0100 (+0.03%) info
Market Cap: $1.158B info
AMTB
Jul 23, 2026, 4:07 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $25.85
Real-time Price: $29.56 info
Change: +$3.71 (+14%) info
Market Cap: $1.158B info
AMTB
Jul 23, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $25.85
Real-time Price: $29.56 info
Change: +$3.71 (+14%) info
Market Cap: $1.158B info
AMTB
Jun 17, 2026, 4:31 PM EDT
Filing Type: 8-K/A
Importance Score:
7
Price at Filing: $23.23
Real-time Price: $29.56 info
Change: +$6.33 (+27%) info
Market Cap: $1.158B info
AMTB
Jun 12, 2026, 4:06 PM EDT
Filing Type: S-3ASR
Importance Score:
7
Price at Filing: $23.91
Real-time Price: $29.56 info
Change: +$5.65 (+24%) info
Market Cap: $1.158B info